MelissaGarigBrammerMD
Oncology • South San Francisco, CABreast Cancer, Hematologic Oncology
Group Medical Director, Genentech
Dr. Brammer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Dna Way
South San Francisco, CA 94080Phone+1 650-467-7700
Education & Training
Tulane UniversityFellowship, Hematology and Medical Oncology, 1983 - 1986- Tulane UniversityResidency, Internal Medicine, 1980 - 1983
- Tulane University School of MedicineClass of 1980
Certifications & Licensure
LA State Medical License 1980 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 277 citationsCentral Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHERAdam Brufsky, Musa Mayer, Hope S. Rugo, Peter A. Kaufman, Elizabeth Tan-Chiu
Clinical Cancer Research. 2011-07-15 - 49 citationsAssessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer.Peter A. Kaufman, Kenneth J. Bloom, Howard A. Burris, Julie R. Gralow, Musa Mayer
Cancer. 2014-09-01 - 11 citationsEffect of Central Nervous System Metastases on Treatment Discontinuation and Survival in Older Women Receiving Trastuzumab for Metastatic Breast CancerMark D. Danese, Karla Lindquist, Justin F. Doan, Deepa Lalla, Melissa Brammer
Journal of Cancer Epidemiology. 2012-04-09
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
